Vascular calcification: Mechanisms of vascular smooth muscle cell calcification

Trends in Cardiovascular Medicine

Volumn 25, Issue 4, 2015, Pages 267-274

  Leopold, Jane A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE;

APOPTOSIS; ATHEROSCLEROTIC PLAQUE; AUTOPHAGY; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; EXOSOME; HEREDITY; HORMONAL REGULATION; HUMAN; LIPID STORAGE; NEOINTIMA; NONHUMAN; OSSIFICATION; OSTEOBLAST; OXIDATIVE STRESS; PHENOTYPE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; EVIDENCE BASED MEDICINE; METABOLISM; PATHOLOGY; PREVALENCE; RISK FACTOR; SEX RATIO; SMOOTH MUSCLE CELL; UNITED STATES; VASCULAR CALCIFICATION; VASCULAR SMOOTH MUSCLE;

AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES; VASCULAR CALCIFICATION;

EID: 84928733216     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2014.10.021     Document Type: Review

References (66)

1. Bild D.E., Detrano R., Peterson D., Guerci A., Liu K., Shahar E., et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005, 111:1313-1320.
2. Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New Engl J Med 2008, 358:1336-1345.
3. DeFilippis A.P., Blaha M.J., Ndumele C.E., Budoff M.J., Lloyd-Jones D.M., McClelland R.L., et al. The association of Framingham and Reynolds risk scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2011, 58:2076-2083.
4. Wong N.D., Kouwabunpat D., Vo A.N., Detrano R.C., Eisenberg H., Goel M., et al. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am Heart J 1994, 127:422-430.
5. Okwuosa T.M., Greenland P., Burke G.L., Eng J., Cushman M., Michos E.D., et al. Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging 2012, 5:144-153.
6. Rennenberg R.J., Kessels A.G., Schurgers L.J., van Engelshoven J.M., de Leeuw P.W., Kroon A.A. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 2009, 5:185-197.
7. Otsuka F., Sakakura K., Yahagi K., Joner M., Virmani R. Has our understanding of calcification in human coronary atherosclerosis progressed?. Arterioscler Thromb Vasc Biol 2014, 34:724-736.
8. Bostrom K.I., Rajamannan N.M., Towler D.A. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res 2011, 109:564-577.
9. Westendorf J.J., Kahler R.A., Schroeder T.M. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341:19-39.
10. Hill T.P., Spater D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005, 8:727-738.
11. Bodine P.V., Komm B.S. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord 2006, 7:33-39.
12. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., et al. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 2006, 7:1-16.
13. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
14. Zhu F., Friedman M.S., Luo W., Woolf P., Hankenson K.D. The transcription factor osterix (SP7) regulates BMP6-induced human osteoblast differentiation. J Cell Physiol 2012, 227:2677-2685.
15. Shao J.S., Cheng S.L., Pingsterhaus J.M., Charlton-Kachigian N., Loewy A.P., Towler D.A. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005, 115:1210-1220.
16. -/- mice. Arterioscler Thromb Vasc Biol 2007, 27:2589-2596.
17. Steitz S.A., Speer M.Y., Curinga G., Yang H.Y., Haynes P., Aebersold R., et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001, 89:1147-1154.
18. Speer M.Y., Yang H.Y., Brabb T., Leaf E., Look A., Lin W.L., et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009, 104:733-741.
19. Yoshida T., Yamashita M., Hayashi M. Kruppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells. J Biol Chem 2012, 287:25706-25714.
20. Leopold J.A. MicroRNAs regulate vascular medial calcification. Cells 2014, 3:963-980.
21. Goettsch C., Hutcheson J.D., Aikawa E. MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms. Circ Res 2013, 112:1073-1084.
22. Balderman J.A., Lee H.Y., Mahoney C.E., Handy D.E., White K., Annis S., et al. Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J Am Heart Assoc 2012, 1:e003905.
23. Goettsch C., Rauner M., Pacyna N., Hempel U., Bornstein S.R., Hofbauer L.C. miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol 2011, 179:1594-1600.
24. Demer L.L., Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol 2014, 34:715-723.
25. Kapustin A.N., Shanahan C.M. Calcium regulation of vascular smooth muscle cell-derived matrix vesicles. Trends Cardiovasc Med 2012, 22:133-137.
26. Lee K., Kim H., Jeong D. Microtubule stabilization attenuates vascular calcification through the inhibition of osteogenic signaling and matrix vesicle release. Biochem Biophys Res Commun 2014, 451:436-441.
27. Kapustin A.N., Davies J.D., Reynolds J.L., McNair R., Jones G.T., Sidibe A., et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 2011, 109:e1-12.
28. Chen N.X., O'Neill K., Chen X., Kiattisunthorn K., Gattone V.H., Moe S.M. Transglutaminase 2 accelerates vascular calcification in chronic kidney disease. Am J Nephrol 2013, 37:191-198.
29. Kapustin A., Chatrou M., Kalra S., Drozdov I., Soong D., Furmanik M., et al. Regulated exosome secretion by vascular smooth muscle cells mediates vascular calcification. Heart 2014, 100(suppl. 3):A93-A94.
30. Herrmann M., Schafer C., Heiss A., Graber S., Kinkeldey A., Buscher A., et al. Clearance of fetuin-A-containing calciprotein particles is mediated by scavenger receptor-A. Circ Res 2012, 111:575-584.
31. Jahnen-Dechent W., Heiss A., Schafer C., Ketteler M. Fetuin-A regulation of calcified matrix metabolism. Circ Res 2011, 108:1494-1509.
32. Byon C.H., Javed A., Dai Q., Kappes J.C., Clemens T.L., Darley-Usmar V.M., et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008, 283:15319-15327.
33. Sutra T., Morena M., Bargnoux A.S., Caporiccio B., Canaud B., Cristol J.P. Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media. Free Radical Res 2008, 42:789-797.
34. Wei Q., Ren X., Jiang Y., Jin H., Liu N., Li J. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. BMC Cardiovasc Disord 2013, 13:13.
35. Brodeur M.R., Bouvet C., Bouchard S., Moreau S., Leblond J., Deblois D., et al. Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes. PLoS One 2014, 9:e85922.
36. Cheng S.L., Shao J.S., Halstead L.R., Distelhorst K., Sierra O., Towler D.A. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res 2010, 107:271-282.
37. Brodeur M.R., Bouvet C., Barrette M., Moreau P. Palmitic acid increases medial calcification by inducing oxidative stress. J Vasc Res 2013, 50:430-441.
38. Liberman M., Johnson R.C., Handy D.E., Loscalzo J., Leopold J.A. Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic. Biochem Biophys Res Commun 2011, 413:436-441.
39. Duan X.H., Chang J.R., Zhang J., Zhang B.H., Li Y.L., Teng X., et al. Activating transcription factor 4 is involved in endoplasmic reticulum stress-mediated apoptosis contributing to vascular calcification. Apoptosis 2013, 18:1132-1144.
40. Masuda M., Miyazaki-Anzai S., Levi M., Ting T.C., Miyazaki M. PERK-eIF2alpha-ATF4-CHOP signaling contributes to TNFalpha-induced vascular calcification. J Am Heart Assoc 2013, 2:e000238.
41. Miyazaki-Anzai S., Masuda M., Demos-Davies K.M., Keenan A.L., Saunders S.J., Masuda R., et al. Endoplasmic reticulum stress effector CCAAT/enhancer-binding protein homologous protein (CHOP) regulates chronic kidney disease-induced vascular calcification. J Am Heart Assoc 2014, 3:e000949.
42. Liu Y., Drozdov I., Shroff R., Beltran L.E., Shanahan C.M. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ Res 2013, 112:e99-109.
43. Dai X.Y., Zhao M.M., Cai Y., Guan Q.C., Zhao Y., Guan Y., et al. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int 2013, 83:1042-1051.
44. Proudfoot D., Skepper J.N., Hegyi L., Bennett M.R., Shanahan C.M., Weissberg P.L. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000, 87:1055-1062.
45. Ewence A.E., Bootman M., Roderick H.L., Skepper J.N., McCarthy G., Epple M., et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 2008, 103:e28-e34.
46. Schurgers L.J., Spronk H.M., Skepper J.N., Hackeng T.M., Shanahan C.M., Vermeer C., et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007, 5:2503-2511.
47. Lomashvili K.A., Wang X., Wallin R., O'Neill W.C. Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J Biol Chem 2011, 286:28715-28722.
48. Lomashvili K.A., Narisawa S., Millan J.L., O'Neill W.C. Vascular calcification is dependent on plasma levels of pyrophosphate. Kidney Int 2014, 85:1351-1356.
49. Villa-Bellosta R., Rivera-Torres J., Osorio F.G., Acin-Perez R., Enriquez J.A., Lopez-Otin C., et al. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment. Circulation 2013, 127:2442-2451.
50. Kauffenstein G., Pizard A., Le Corre Y., Vessieres E., Grimaud L., Toutain B., et al. Disseminated arterial calcification and enhanced myogenic response are associated with abcc6 deficiency in a mouse model of pseudoxanthoma elasticum. Arterioscler Thromb Vasc Biol 2014, 34:1045-1056.
51. Lau W.L., Liu S., Vaziri N.D. Chronic Kidney Disease Results in Deficiency of ABCC6, the Novel Inhibitor of Vascular Calcification. Am J Nephrol 2014, 40:51-55.
52. Nitschke Y., Baujat G., Botschen U., Wittkampf T., du Moulin M., Stella J. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Gen 2012, 90:25-39.
53. Westenfeld R., Schafer C., Smeets R., Brandenburg V.M., Floege J., Ketteler M., et al. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Trans 2007, 22:1537-1546.
54. Callegari A., Coons M.L., Ricks J.L., Rosenfeld M.E., Scatena M. Increased calcification in osteoprotegerin-deficient smooth muscle cells: dependence on receptor activator of NF-kappaB ligand and interleukin 6. J Vasc Res 2014, 51:118-131.
55. Panizo S., Cardus A., Encinas M., Parisi E., Valcheva P., Lopez-Ongil S., et al. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 2009, 104:1041-1048.
56. Rzewuska-Lech E., Jayachandran M., Fitzpatrick L.A., Miller V.M. Differential effects of 17beta-estradiol and raloxifene on VSMC phenotype and expression of osteoblast-associated proteins. Am J Physiol 2005, 289:E105-E112.
57. Osako M.K., Nakagami H., Koibuchi N., Shimizu H., Nakagami F., Koriyama H., et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res 2010, 107:466-475.
58. McRobb L., Handelsman D.J., Heather A.K. Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. Endocrinology 2009, 150:841-848.
59. Son B.K., Akishita M., Iijima K., Ogawa S., Maemura K., Yu J., et al. Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification. J Biol Chem 2010, 285:7537-7544.
60. Neves K.R., Graciolli F.G., dos Reis L.M., Graciolli R.G., Neves C.L., Magalhaes A.O., et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 2007, 71:1262-1270.
61. Sebastian E.M., Suva L.J., Friedman P.A. Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure. Bone 2008, 43:1022-1030.
62. Hruska K.A., Mathew S., Lund R.J., Memon I., Saab G. The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature. Semin Nephrol 2009, 29:156-165.
63. Lim K., Lu T.S., Molostvov G., Lee C., Lam F.T., Zehnder D., et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 2012, 125:2243-2255.
64. Norman P.E., Powell J.T. Vitamin D and cardiovascular disease. Circ Res 2014, 114:379-393.
65. Voelkl J., Alesutan I., Leibrock C.B., Quintanilla-Martinez L., Kuhn V., Feger M., et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 2013, 123:812-822.
66. Jaffe I.Z., Tintut Y., Newfell B.G., Demer L.L., Mendelsohn M.E. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol 2007, 27:799-805.